Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419547 · ClinicalTrials.gov registry record · NA
Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02419547 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 11 participants.
The verdict
NCT02419547, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This research study is being done to see whether general anesthesia (GA) affects our ability to start ventricular tachycardia (VT) during an VT ablation procedure. Data collected during this research study will help electrophysiologists and anesthesiologists to make the best decisions about the best anesthetic conditions to use to perform VT ablations. This research study is a "pilot" study. Pilot studies are done on a small group of subjects to learn if a larger study would be useful.
Interventions
- DRUG Sevoflurane
- DRUG Propofol
- DRUG Fentanyl
- DRUG Versed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02419547
The ClinicalTrials.gov registry entry for NCT02419547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sevoflurane is the first listed.
NCT02419547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02419547 about?
NCT02419547 is a clinical study titled "Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia". This research study is being done to see whether general anesthesia (GA) affects our ability to start ventricular tachycardia (VT) during an VT ablation procedure. Data collected during this research study will help electrophysiologists and anesthesiologists to make the best decisions about the bes...
What is the current status of trial NCT02419547?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-07. Estimated completion is 2015-04-26.
What interventions are being tested in trial NCT02419547?
The interventions under investigation include: Sevoflurane (DRUG), Propofol (DRUG), Fentanyl (DRUG), Versed (DRUG).
Who is sponsoring clinical trial NCT02419547?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.